Emergent Product Development Gaithersburg Inc
- View government funding actions
- Gaithersburg, MD 208793419
- Phone: 240-486-5942
- Estimated Number of Employees: 600
- Estimated Annual Receipts: $150,000,000
- Business Start Date: 2003
- Contact Person: Diana Ororbia-knapton
- Contact Phone: 240-631-6466
- Contact Email: knaptond@ebsi.com
- Business Structure:
- Corporate Entity (Not Tax Exempt)
- Business Type:
- For Profit Organization
- Manufacturer of Goods
- Industries Served: Research and Development in Biotechnology
- Product Areas: R&D- OTHER RESEARCH AND DEVELOPMENT (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT), R&D-OTHER R & D-A RES/EXPL DEV
Sampling of Federal Government Funding Actions/Set Asides
In order by amount of set aside monies.
- $19,974,300 - Saturday the 1st of August 2015
Office Of Assistant Secretary For Administration And Management
OFF ASST SEC ADM AND MGMT
TAS::75 0140::TAS ADVANCED DEVELOPMENT OF RECOMBINANT PROTECTIVE ANTIGENT (RPA) ANTHRAX VACCINE CAN 1990087 - $14,455,413 - Friday the 7th of September 2012
National Institutes Of Health
NIH, NIAID DEA OA OFC ACQUISITIONS
TAS::75 0885::TAS DEVELOPMENT OF TECHNOLOGIES TO FACILITATE THE USE OF, AND RESPONSE TO, BIODEFENSE VACCINES
© Copyright 2019
The Collier Report published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources.
No reliance should be made by readers or Collier Report subscribers.
Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances.
Requests for the modification of displayed information may be made to help.desk@1918.media.